Search for: "Teva Pharmaceuticals" Results 561 - 580 of 1,424
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Defendant’s Stipulation to Infringement "Under the Present Claim Construction" Does Not Justify Change in Order of Proof at Trial​
29 Aug 2017, 7:35 am by Docket Navigator
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED August 25, 2017, Order) (Bryson, CJ) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Why do we have suddenly increasing drug prices?
26 Aug 2016, 7:25 am by Lawrence B. Ebert
One potential EpiPen competitor, Teva Pharmaceuticals, failed to obtain regulatory approval, delaying their entry into the market Another competitor, Sanofi, recalled its competing epinephrine delivery device because it may be delivering in incorrect dosage. [read post]
IPBiz - http://ipbiz.blogspot.com/
Copying in ANDA Case Not Compelling Evidence of Nonobviousness
20 Feb 2013, 7:37 am by Docket Navigator
Teva Pharmaceuticals USA Inc., et. al., 1-10-cv-00805 (DED February 11, 2013, Order) (Burke, M.J.). [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Attorney Fees for Resisting Motion to Compel Not Recoverable
12 Apr 2017, 7:13 am by Docket Navigator
Teva Pharmaceuticals USA, Inc. et al, 2-15-cv-01455 (TXED April 10, 2017, Order) (Bryson, CJ) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Federal Circuit Hands Mixed Ruling to Momenta on 271(g) and 271(e)(1) Issues
10 Nov 2015, 3:39 pm by Aaron Barkoff
Teva, No. 2014-1274 (Fed. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Federal Circuit Hands Mixed Ruling to Momenta on 271(g) and 271(e)(1) Issues
10 Nov 2015, 3:39 pm by Aaron Barkoff
Teva, No. 2014-1274 (Fed. [read post]
Orange Book Blog - http://www.orangebookblog.com/
Is article 3 (a) of the Regulation (EC) 469/2009 disappearing into the mist, or is clarity round the corner?
22 Sep 2019, 11:48 pm
Certain concerns were in fact expressed with regards to the effects this interpretation would have on early stage patents and how this in its turn would influence research (let alone strategic decisions) in the pharmaceutical sector. [read post]
IPKat - http://ipkitten.blogspot.com/
FDA Issues Warning About Counterfeit Adderall
3 Jun 2012, 6:15 pm by Mark Zamora
Bradley said two incidents have been reported to the FDA, and Teva Pharmaceuticals continues to work with the FDA on the investigation.http://www.krdo.com/health/31134307/detail.html [read post]
A Georgia Lawyer - http://ageorgialawyer.blogspot.com/
Biovail Continues to Fight FDA, Anchen, Impax, and Teva to Protect Wellbutrin XL
11 Jan 2007, 2:52 pm
  Teva intevened, filing its own opposition brief. [read post]
Orange Book Blog - http://www.orangebookblog.com/
MILLENNIUM PHARMACEUTICALS scores win at CAFC in '446 (Velcade® ) case; Judge Newman explicates obviousness
17 Jul 2017, 9:41 am by Lawrence B. Ebert
Teva Pharm. [read post]
IPBiz - http://ipbiz.blogspot.com/
When compounds in a class have divergent properties, positional isomer not obvious
18 May 2009, 7:00 am
Teva Pharms. [read post]
Filewrapper.com - http://www.filewrapper.com/index.cfm
Lilly Wins Appeal Protecting Attention-Deficit Disorder Drug Patent
1 Aug 2011, 8:19 am
The seven defendants, Actavis Elizabeth LLC, Sun Pharmaceuticals, Sandoz Inc., Mylan Pharmaceuticals, Apotex Inc., Aurobindo Pharma Ltd., and Teva Pharmaceuticals, had filed an Abbreviated New Drug Application (ANDA) seeking to utilize Lilly's patented formula and claiming invalidity of Lilly's patent, No. 5,658,590, Treatment of attention-deficit/hyperactivity disorder, which has been issued by the US Patent Office. [read post]
Indiana Intellectual Property Lawyer Blog - http://www.iniplaw.org/
Indiana Patent Litigation: Lilly Brings Another Defendant into Effient Patent Infringement Litigation
17 Jul 2014, 10:58 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global Inc.; Sun Pharmaceutical… [read post]
Indiana Intellectual Property Lawyer Blog - http://www.iniplaw.org/
Indiana Patent Infringement Litigation: Eli Lilly Sues Numerous Defendants
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma… [read post]
Indiana Intellectual Property Lawyer Blog - http://www.iniplaw.org/
Indiana Patent Litigation - Lilly Adds Panacea Biotec to List of Patent Infringement Defendants
30 Jun 2014, 10:28 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.; Sun Pharma Global Inc.; Sun Pharmaceutical… [read post]
Indiana Intellectual Property Lawyer Blog - http://www.iniplaw.org/
Teva v. AstraZeneca - Does an Inventor Need to Understand How a Prior Invention Works in Order to Have that Prior Invention Defeat Another's Patent?
11 Dec 2011, 9:00 pm by Stephanie Figueroa
., Partner at Birch Stewart Kolasch & Birch, LLP On December 1, in Teva Pharmaceutical Ind. [read post]
Patent Law Practice Center - http://patentlawcenter.pli.edu
Teva v. AstraZeneca - Does an Inventor Need to Understand How a Prior Invention Works in Order to Have that Prior Invention Defeat Another's Patent?
11 Dec 2011, 9:00 pm by Stephanie Figueroa
., Partner at Birch Stewart Kolasch & Birch, LLP On December 1, in Teva Pharmaceutical Ind. [read post]
Patent Law Practice Center - http://patentlawcenter.pli.edu/
Status Quo Vadis?
17 Oct 2023, 3:40 pm by Rik Lambers (Brinkhof)
Teva was issues a Dutch marketing authorisation for a generic version of Nebido with the brand name Testosterone Teva in December 2022. [read post]
Kluwer Patent Blog - http://patentblog.kluweriplaw.com/
CAFC explicates Mayo, Vanda in Endo v. Teva
28 Mar 2019, 11:01 am by Lawrence B. Ebert
West-Ward Pharmaceuticals International Ltd, 887 F.3d 1117 (Fed. [read post]
IPBiz - http://ipbiz.blogspot.com/
Federal Circuit’s Sleepy Obviousness Decision and Vanda’s En Banc Rehearing Petition
31 Jul 2023, 12:48 pm by Dennis Crouch
This case provides an interesting look at the application of the obviousness standard to pharmaceutical treatment methods. [read post]
Patently-O - https://patentlyo.com